3SBio Inc. (HKG:1530)
Hong Kong · Delayed Price · Currency is HKD 14.70
+0.77 (5.53%)
Nov 4, 2026, 2:44 PM HKT
3SBio Market Cap
3SBio has a market cap or net worth of 36.64 billion as of November 3, 2026. It is the 3,872nd most valuable company in the world and the 194th biggest in Hong Kong. Its market cap has decreased by 51.81% in one year.
Market Cap
36.64B
Enterprise Value
21.83B
Revenue
20.63B
Global Rank
Country Rank
#194 Hong Kong
PE Ratio
3.92
ChartMarket Cap Chart
Since June 11, 2015, 3SBio's market cap has increased from 22.67B to 36.64B, an increase of 61.62%. That is a compound annual growth rate of 4.30%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 4, 2026 | 36.64B | -39.34% |
| Dec 31, 2025 | 60.39B | 321.75% |
| Dec 31, 2024 | 14.32B | -20.61% |
| Dec 29, 2023 | 18.04B | -10.89% |
| Dec 30, 2022 | 20.24B | 23.46% |
| Dec 31, 2021 | 16.40B | -8.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Sino Biopharmaceutical | 87.00B |
| Akeso | 72.56B |
| Genscript Biotech | 68.92B |
| RemeGen | 49.91B |
| Biocytogen Pharmaceuticals (Beijing) | 32.20B |
| Shanghai Junshi Biosciences | 30.39B |
| Shanghai Henlius Biotech | 25.31B |
| InnoCare Pharma | 23.70B |